76 related articles for article (PubMed ID: 29982588)
1. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
Ning T; Nie J; Huang W; Li C; Li X; Liu Q; Zhao H; Wang Y
J Infect Dis; 2019 Jan; 219(1):19-25. PubMed ID: 29982588
[TBL] [Abstract][Full Text] [Related]
2. Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity.
Chang P; Sealy JE; Sadeyen JR; Iqbal M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30282714
[TBL] [Abstract][Full Text] [Related]
3. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
Henry Dunand CJ; Leon PE; Huang M; Choi A; Chromikova V; Ho IY; Tan GS; Cruz J; Hirsh A; Zheng NY; Mullarkey CE; Ennis FA; Terajima M; Treanor JJ; Topham DJ; Subbarao K; Palese P; Krammer F; Wilson PC
Cell Host Microbe; 2016 Jun; 19(6):800-13. PubMed ID: 27281570
[TBL] [Abstract][Full Text] [Related]
4. Evolution and Antigenic Differentiation of Avian Influenza A(H7N9) Virus, China.
Liu Y; Chen Y; Yang Z; Lin Y; Fu S; Chen J; Xu L; Liu T; Niu B; Huang Q; Liu H; Zheng C; Liao M; Jia W
Emerg Infect Dis; 2024 Jun; 30(6):1218-1222. PubMed ID: 38640498
[TBL] [Abstract][Full Text] [Related]
5. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.
De Groot AS; Moise L; Liu R; Gutierrez AH; Terry F; Koita OA; Ross TM; Martin W
Hum Vaccin Immunother; 2014; 10(2):256-62. PubMed ID: 24525618
[TBL] [Abstract][Full Text] [Related]
6. Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles.
Jang H; Ross TM
PLoS One; 2021; 16(3):e0246613. PubMed ID: 33735274
[TBL] [Abstract][Full Text] [Related]
7. Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.
Chen C; Liu L; Xiao Y; Cui S; Wang J; Jin Q
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212936
[TBL] [Abstract][Full Text] [Related]
8. Structural and Molecular Characterization of the Hemagglutinin from the Fifth-Epidemic-Wave A(H7N9) Influenza Viruses.
Yang H; Carney PJ; Chang JC; Guo Z; Stevens J
J Virol; 2018 Aug; 92(16):. PubMed ID: 29848588
[TBL] [Abstract][Full Text] [Related]
9. Deep Sequencing of H7N9 Influenza A Viruses from 16 Infected Patients from 2013 to 2015 in Shanghai Reveals Genetic Diversity and Antigenic Drift.
Xiao YL; Ren L; Zhang X; Qi L; Kash JC; Xiao Y; Wu F; Wang J; Taubenberger JK
mSphere; 2018 Sep; 3(5):. PubMed ID: 30232169
[TBL] [Abstract][Full Text] [Related]
10. Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Bahl K; Senn JJ; Yuzhakov O; Bulychev A; Brito LA; Hassett KJ; Laska ME; Smith M; Almarsson Ö; Thompson J; Ribeiro AM; Watson M; Zaks T; Ciaramella G
Mol Ther; 2017 Jun; 25(6):1316-1327. PubMed ID: 28457665
[TBL] [Abstract][Full Text] [Related]
11. Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck.
Zaraket H; Baranovich T; Kaplan BS; Carter R; Song MS; Paulson JC; Rehg JE; Bahl J; Crumpton JC; Seiler J; Edmonson M; Wu G; Karlsson E; Fabrizio T; Zhu H; Guan Y; Husain M; Schultz-Cherry S; Krauss S; McBride R; Webster RG; Govorkova EA; Zhang J; Russell CJ; Webby RJ
Nat Commun; 2015 Apr; 6():6553. PubMed ID: 25850788
[TBL] [Abstract][Full Text] [Related]
12. Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.
Tharakaraman K; Jayaraman A; Raman R; Viswanathan K; Stebbins NW; Johnson D; Shriver Z; Sasisekharan V; Sasisekharan R
Cell; 2013 Jun; 153(7):1486-93. PubMed ID: 23746830
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of influenza H7 hemagglutinin-mediated entry.
Antanasijevic A; Cheng H; Wardrop DJ; Rong L; Caffrey M
PLoS One; 2013; 8(10):e76363. PubMed ID: 24194835
[TBL] [Abstract][Full Text] [Related]
14. MDCK-Adaptive Mutation of A169S Changes Glycosylation Pattern of Hemagglutinin and Enhances MDCK-Based H7N9 Vaccine Virus Production without Loss of Antigenicity and Immunogenicity.
Chen PL; Weng TC; Lai CC; Tzeng TT; Lin MH; Hu KC; Hu AY; Lee MS; Sung WC
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543924
[TBL] [Abstract][Full Text] [Related]
15. Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design.
Hu Z; Jiao X; Liu X
Front Microbiol; 2017; 8():1898. PubMed ID: 29018438
[TBL] [Abstract][Full Text] [Related]
16. Convolutional Neural Network Based Approach to in Silico Non-Anticipating Prediction of Antigenic Distance for Influenza Virus.
Forghani M; Khachay M
Viruses; 2020 Sep; 12(9):. PubMed ID: 32932748
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin is effective against drug-resistant H7N9 influenza virus infections.
Bi Y; Wong G; Liu Y; Liu L; Gao GF; Shi Y
Protein Cell; 2016 Aug; 7(8):611-4. PubMed ID: 27430950
[No Abstract] [Full Text] [Related]
18. Allosteric Neutralization by Human H7N9 Antibodies.
Jia M; Zhao H; Morano NC; Lu H; Lui YM; Du H; Becker JE; Yuen KY; Ho DD; Kwong PD; Shapiro L; To KK; Wu X
Res Sq; 2023 Nov; ():. PubMed ID: 37986867
[TBL] [Abstract][Full Text] [Related]
19. Handheld real-time PCR device.
Ahrberg CD; Ilic BR; Manz A; Neužil P
Lab Chip; 2016 Feb; 16(3):586-92. PubMed ID: 26753557
[TBL] [Abstract][Full Text] [Related]
20. Influenza A(H7N9) Virus Evolution: Which Genetic Mutations Are Antigenically Important?
Petrie JG; Lauring AS
J Infect Dis; 2019 Jan; 219(1):3-5. PubMed ID: 29982612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
